SCHEMBL4151865

SCHEMBL4151865

O=C(c1ccc(O)cc1O)N1CCC(CCc2ncccn2)CC1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.46
HTR2C P28335 2/20 0.46
HSP90AB1 P08238 6/20 0.46
HSP90AA1 P07900 5/20 0.46
GRIN2D O15399 1/20 0.45
GRIN3B O60391 1/20 0.45
GRIN1 Q05586 1/20 0.45
GRIN2A Q12879 1/20 0.45
GRIN2B Q13224 1/20 0.45
GRIN2C Q14957 1/20 0.45
GRIN3A Q8TCU5 1/20 0.45
PDK1 Q15118 4/20 0.43
PDK2 Q15119 2/20 0.43
PDK3 Q15120 2/20 0.43
PDK4 Q16654 2/20 0.43
MGLL Q99685 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4145949 0.83 GRIN2D (0.63) HTR2AHTR2CHSP90AB1HSP90AA1GRIN2D
SCHEMBL4151498 0.82 PDK1 (0.42) HTR2AHTR2CHSP90AB1HSP90AA1GRIN2D
SCHEMBL4146438 0.81 GRIN2D (0.47) HTR2AHTR2CHSP90AB1HSP90AA1GRIN2D
SCHEMBL4147402 0.79 HSP90AB1 (0.51) HSP90AB1HSP90AA1PDK1PDK2PDK3
SCHEMBL4151385 0.79 GRIN2D (0.50) HTR2AHTR2CHSP90AB1HSP90AA1GRIN2D
SCHEMBL3792423 0.77 HSP90AA1 (0.51) HSP90AB1HSP90AA1PDK1PDK2PDK3
SCHEMBL4151901 0.77 SPR (0.62) HSP90AB1HSP90AA1GRIN2DGRIN3BGRIN1
SCHEMBL9785745 0.76 CYP2C9 (0.63) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL4155107 0.74 HSP90AA1 (0.50) HSP90AB1HSP90AA1PDK1PDK2PDK3
SCHEMBL4159615 0.73 HSP90AA1 (0.55) HSP90AB1HSP90AA1PDK1PDK2PDK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS PFIZER, INC. 2009-08-27 US claimed
EP-1879863-A1 AMIDE RESORCINOL COMPOUNDS Pfizer, Inc. (US) 2008-01-23 EP claimed
WO-2006117669-A1 AMIDE RESORCINOL COMPOUNDS PFIZER INC. (US) 2006-11-09 WO claimed
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS PFIZER, INC. 2009-08-27 US disclosed
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS PFIZER, INC. 2009-08-27 US disclosed
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS PFIZER, INC. 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS HSP90AB1, HSP90AA1, HSP90AB2P HTR2A 2407/4885HTR2C 3342/4885HSP90AB1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.